In the realm of molecular biology and protein biochemistry, the study of the sumo peptide sequence remains a cornerstone for researchers aiming to optimize protein expression and structural analysis. Small Ubiquitin-like Modifier (SUMO) proteins belong to a unique family of regulatory proteins that are pivotal in post-translational modifications. My personal experience working with these systems suggests that understanding the structural integrity of these tags is essential for anyone involved in high-yield recombinant production.
The Structural Architecture of SUMO Proteins
SUMO (Small Ubiquitin-like Modifier) proteins are fascinating due to their evolutionary conservation. Current research indicates that SUMO exists in four different isoforms, SUMO-1, -2, -3, -4, each possessing distinct functional characteristics. Notably, SUMO-2, -3, and -4 are closely related, sharing a high degree of homology, whereas SUMO1 is the most unique of the four identified SUMO proteins.
When analyzing these sequences, one often encounters the consensus binding motif with amino acid sequence Φ-K-X-D/E, where Φ represents a large hydrophobic residue and X is any residue. This specific sequence ΦKxD/E serves as the target site for sumoylation. In my laboratory observations, the disti Sumo Blocking Peptide ; Reactive Species. Human ; Product Concentration. 0.2 mg/ml ; Amino Acid Location.14 amino acids near the amino-terminus of human Sumo. nction between these isoforms is critical, especially when comparing SUMO-1, SUMO-2, SUMO-3, SUMO-4M, and SUMO-4V, as their tertiary structures dictate how they interact with cellular machinery.
Strategic Application in Expression Systems
For Small Peptide Binding Stiffens the Ubiquitin-like Protein SUMO1 those focusing on protein purificat SUMO Protease, Biotin-tagged ion, the pET SUMO expression system is a widely utilized tool. It provides a forward and reverse sequencing primer to facilitate the analysis of expression constructs. A key advantage I have noted is that SUMO fusion proteins do not require an additional cleavage sequence. This is because SUMO proteases recognize the tertiary structure of the SUMO tag rather than a linear peptide sequence.
This mechanism allows for cle The gene of interest is placed immediately after theSUMOgene in order to preclude the introduction of undesirableamino-acidresidues at the junction. aner processing, as the protease—which is a recombinant fragment of Ulp1—effectively isolates the desired protein. The use of a linearized bacterial vector with 3'-T overhangs further streamlines the workflow, allowing for efficient TA cloning.
Practical Insights for Laboratory Usage
When setting up experiments, consider the following technical observations:
* Fusion Strategy: The Sumo tag is most frequently used as N-end fusion sequence to significantly enhance solubility. This method maximizes the yield of soluble, functional proteins in E. coli, which is often a bottleneck in recombinant production.
* Sequence Analysis: Whether you are working with Human SUMO2 (sentrin 3, Smt3a) or other variants, always account for the specif Our SUMO-tag expression systemmaximizes the yield of soluble, functional proteins in E. coli. SUMO functions as both a chaperone and initiator of protein ic amino-acid composition at the junction. Precision here prevents the introduction of unnecessary residues.
* Verification: If you are using a Sumo Blocking Peptide, note that it typically contains 14 amino acids near the amino-terminus of human Sumo, providing a targeted control for binding studies.
Comparing Components and Variations
In my experience, comparing sequences is vital. For instance, while Calmodulin, His•Tag Human, Recombinant products might be used in similar contexts, they differ fundamentally from the SUMO system in their interaction motifs. Researchers often utilize small peptide sequences within target proteins—known as SUMO-interacting motifs (SIMs)—to study noncovalent interactions.
Whether you are performing a simple sequence verification or complex structural mapping, the robustness of the SUMO system lies in its reliance on thre SUMO Gene Fusion Technology e-dimensional recognition. By focusing on the sp (d)Sequencesof peptides used in this study. Putative cleavage sites observed duringSUMOfusion expression are indicated by the red, vertical lines. Cleavage ecific properties of the SUMO protein and its isoforms, one can ensure higher consistency in experimental outcomes. Always verify your construct design against canonical entries to maintain the integrity of your research data.